These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36763000)

  • 1. The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device.
    Jeon H; Jeon J; Lee K; Kim D; Cho YH; Lee JE; Choi JO; Huh W; Kim YG; Jeon ES; Jang HR
    Ren Fail; 2023 Dec; 45(1):2157285. PubMed ID: 36763000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery after acute kidney injury requiring kidney replacement therapy in patients with left ventricular assist device: A meta-analysis.
    Kovvuru K; Kanduri SR; Thongprayoon C; Bathini T; Vallabhajosyula S; Kaewput W; Mao MA; Cheungpasitporn W; Kashani KB
    World J Crit Care Med; 2021 Nov; 10(6):390-400. PubMed ID: 34888164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart, kidney and left ventricular assist device: a complex trio.
    Gambaro A; Lombardi G; Onorati F; Gottin L; Ribichini FL
    Eur J Clin Invest; 2021 Dec; 51(12):e13662. PubMed ID: 34347897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Assist Devices and the Kidney.
    Ross DW; Stevens GR; Wanchoo R; Majure DT; Jauhar S; Fernandez HA; Merzkani M; Jhaveri KD
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):348-355. PubMed ID: 29070522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices.
    Parikh U; Lamba H; Ajmal M; Vincent J; Walther C; Shafii A; Nair A; Civitello A; Liao K; Chatterjee S
    J Artif Organs; 2021 Jun; 24(2):207-216. PubMed ID: 33598826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury early after left ventricular assist device implantation: incidence, risk factors and clinical consequences.
    Gündüz E
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3336-3343. PubMed ID: 37140283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device.
    Pinsino A; Mondellini GM; Royzman EA; Hoffman KL; D'Angelo D; Mabasa M; Gaudig A; Zuver AM; Masoumi A; Garan AR; Mohan S; Husain SA; Toma K; Faillace RT; Giles JT; Takeda K; Takayama H; Naka Y; Topkara VK; Demmer RT; Radhakrishnan J; Colombo PC; Yuzefpolskaya M
    Circ Heart Fail; 2020 Jan; 13(1):e006326. PubMed ID: 31959016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Topkara VK; Coromilas EJ; Garan AR; Li RC; Castagna F; Jennings DL; Yuzefpolskaya M; Takeda K; Takayama H; Sladen RN; Mancini DM; Naka Y; Radhakrishnan J; Colombo PC
    Circ Heart Fail; 2016 Dec; 9(12):. PubMed ID: 27932533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes.
    Jawaid O; Gaddy A; Omar HR; Guglin M
    Adv Chronic Kidney Dis; 2021 Jan; 28(1):37-46. PubMed ID: 34389136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Givertz MM; Young JB
    J Heart Lung Transplant; 2013 Dec; 32(12):1205-13. PubMed ID: 24119728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation.
    Asleh R; Schettle S; Briasoulis A; Killian JM; Stulak JM; Pereira NL; Kushwaha SS; Maltais S; Dunlay SM
    Mayo Clin Proc; 2019 Jun; 94(6):1003-1014. PubMed ID: 31171114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Dysfunction in Patients with Left Ventricular Assist Device.
    El Nihum LI; Manian N; Arunachalam P; Al Abri Q; Guha A
    Methodist Debakey Cardiovasc J; 2022; 18(4):19-26. PubMed ID: 36132586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Function in Patients with or without a Left Ventricular Assist Device Implant During Listing for a Heart Transplant.
    Zittermann A; Schramm R; Becker T; von Rössing E; Hinse D; Wlost S; Morshuis M; Gummert JF; Fuchs U
    Ann Transplant; 2020 Nov; 25():e925653. PubMed ID: 33168796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency.
    Pasrija C; Tran D; George P; Sorensen E; Kaczorowski DJ; Ton VK; Kon ZN;
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1307-1319.e2. PubMed ID: 31128896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive kidney function trajectories following left ventricular assist device implantation.
    Walther CP; Benoit JS; Lamba HK; Civitello AB; Erickson KF; Mondal NK; Liao KK; Navaneethan SD
    J Heart Lung Transplant; 2022 Dec; 41(12):1798-1807. PubMed ID: 36182652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device.
    Tibrewala A; Khush KK; Cherikh WS; Foutz J; Stehlik J; Rich JD
    ASAIO J; 2022 May; 68(5):646-653. PubMed ID: 34419984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in Patients with Severe Preexisting Renal Dysfunction After Continuous-Flow Left Ventricular Assist Device Implantation.
    Raichlin E; Baibhav B; Lowes BD; Zolty R; Lyden ER; Vongooru HR; Siddique A; Moulton MJ; Um JY
    ASAIO J; 2016; 62(3):261-7. PubMed ID: 26735558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist devices: a kidney's perspective.
    Tromp TR; de Jonge N; Joles JA
    Heart Fail Rev; 2015 Jul; 20(4):519-32. PubMed ID: 25796403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.